Related Experiment Video
Updated: Jun 19, 2026

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
5.2K
From Lobectomy to Completion Thyroidectomy: A Cohort Study and Systematic Review
Idit Tessler1,2, Tzahi Yamin2, Liroy Caracucli1
1Department of Otolaryngology-Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel.
Clinical Endocrinology
|March 23, 2026
Summary
Completion thyroidectomy is needed for a significant minority of thyroid cancer patients after initial lobectomy, often due to aggressive features. Improved preoperative assessment is crucial for patient selection.
Area of Science:
- Endocrinology
- Surgical Oncology
- Thyroid Cancer Management
Background:
- 2015 American Thyroid Association guidelines suggest lobectomy for low-risk thyroid cancer.
- Precise patient selection is vital to avoid unnecessary completion thyroidectomy (CT).
- Evolving guidelines necessitate evaluating contemporary CT rates and indications.
Purpose of the Study:
- To evaluate current rates and reasons for completion thyroidectomy after initial lobectomy.
- To identify patients at higher risk for completion thyroidectomy.
- To improve preoperative decision-making for thyroid cancer management.
Main Methods:
- Retrospective cohort study of patients undergoing CT (2017-2022).
- Systematic literature review following PRISMA guidelines.
- Analysis of demographics, sonography, cytology, pathology, CT indications, and complications.
Main Results:
- Institutional cohort: 37% of patients underwent CT; average interval 3.75 months.
- Systematic review (30 studies, 23,899 patients): pooled CT rate 19.2%.
- Leading indications: aggressive variants (25.4%), lymph node metastasis (23%), ETE (17.5%). Higher CT rates observed for tumors ≥1cm (45%).
Conclusions:
- Completion thyroidectomy is performed in a significant minority post-lobectomy.
- Adverse pathological findings are the primary drivers for CT.
- Enhanced preoperative risk assessment and patient selection are needed as lobectomy becomes more common.
Related Concept Videos
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

